Hegde JV - Search Results

1

The patient's perspective on breast radiotherapy: Initial fears and expectations versus reality.

Shaverdian N, Wang X, Hegde JV, Aledia C, Weidhaas JB, Steinberg ML, McCloskey SA. Shaverdian N, et al. Among authors: hegde jv. Cancer. 2018 Apr 15;124(8):1673-1681. doi: 10.1002/cncr.31159. Epub 2018 Feb 26. Cancer. 2018. PMID: 29479673 Free article.

2

Maximum tumor diameter and the risk of prostate-specific antigen recurrence after radical prostatectomy.

Rose BS, Chen MH, Zhang D, Hirsch MS, Richie JP, Chang SL, Hegde JV, Loffredo MJ, D'Amico AV. Rose BS, et al. Among authors: hegde jv. Clin Genitourin Cancer. 2014 Oct;12(5):e173-9. doi: 10.1016/j.clgc.2014.03.008. Epub 2014 Mar 28. Clin Genitourin Cancer. 2014. PMID: 24787967

3

The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy.

Shaverdian N, Tenn S, Veruttipong D, Wang J, Hegde J, Lee C, Cao M, Agazaryan N, Steinberg M, Kupelian P, Lee P. Shaverdian N, et al. Br J Radiol. 2016;89(1059):20150963. doi: 10.1259/bjr.20150963. Epub 2016 Jan 14. Br J Radiol. 2016. PMID: 26764282 Free PMC article.

4

A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy.

Hegde JV, Collins SP, Fuller DB, King CR, Demanes DJ, Wang PC, Kupelian PA, Steinberg ML, Kamrava M. Hegde JV, et al. Am J Clin Oncol. 2018 May;41(5):502-507. doi: 10.1097/COC.0000000000000311. Am J Clin Oncol. 2018. PMID: 27322703

5

Establishing the distribution of satellite lesions in intermediate- and high-risk prostate cancer: implications for focused radiotherapy.

Hegde JV, Margolis DJ, Wang PC, Reiter RE, Huang J, Steinberg ML, Kamrava M. Hegde JV, et al. Prostate Cancer Prostatic Dis. 2017 Jun;20(2):241-248. doi: 10.1038/pcan.2016.75. Epub 2017 Jan 31. Prostate Cancer Prostatic Dis. 2017. PMID: 28139757 Free PMC article.

6

Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate Cancer.

Hegde JV, Veruttipong D, Said JW, Reiter RE, Steinberg ML, King CR, Kishan AU. Hegde JV, et al. Urology. 2017 Sep;107:171-177. doi: 10.1016/j.urology.2017.05.028. Epub 2017 May 25. Urology. 2017. PMID: 28552819 Free PMC article.

7

Predictors associated with MRI surveillance screening in women with a personal history of unilateral breast cancer but without a genetic predisposition for future contralateral breast cancer.

Hegde JV, Wang X, Attai DJ, DiNome ML, Kusske A, Hoyt AC, Hurvitz SA, Weidhaas JB, Steinberg ML, McCloskey SA. Hegde JV, et al. Breast Cancer Res Treat. 2017 Nov;166(1):145-156. doi: 10.1007/s10549-017-4392-4. Epub 2017 Jul 12. Breast Cancer Res Treat. 2017. PMID: 28702891

8

Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapy.

Hegde JV, Demanes DJ, Veruttipong D, Raince J, Park SJ, Raman SS, Nickols NG, King CR, Kishan AU, Steinberg ML, Kamrava M. Hegde JV, et al. Brachytherapy. 2017 Nov-Dec;16(6):1106-1112. doi: 10.1016/j.brachy.2017.07.008. Epub 2017 Aug 12. Brachytherapy. 2017. PMID: 28807747

9

Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial.

Hegde JV, Shaverdian N, Daly ME, Felix C, Wong DL, Rosove MH, Garst JH, Wang PC, Veruttipong D, Rao S, Fragoso RC, Riess JW, Steinberg ML, Chen AM. Hegde JV, et al. Cancer. 2018 Feb 1;124(3):521-529. doi: 10.1002/cncr.30954. Epub 2017 Oct 17. Cancer. 2018. PMID: 29044458 Free PMC article. Clinical Trial.

10

Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.

Hegde JV, Wang X, Attai DJ, DiNome ML, Kusske A, Hoyt AC, Hurvitz SA, Weidhaas JB, Steinberg ML, McCloskey SA. Hegde JV, et al. Clin Breast Cancer. 2018 Apr;18(2):e205-e218. doi: 10.1016/j.clbc.2017.09.010. Epub 2017 Sep 27. Clin Breast Cancer. 2018. PMID: 29050918

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters